AAS
DGX icon

Ameritas Advisory Services’s Quest Diagnostics DGX Stock Holding History

Ameritas Advisory Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-90
Closed -$17.2K – 1203
2025
Q3 		$17.2K Sell
90
-105
-54% -$18.6K ﹤0.01% 1491
2025
Q2 		$35K Buy
+195
New +$33.9K ﹤0.01% 1472
2023
Q2 		– Sell
-498
Closed -$71.3K – 1011
2023
Q1 		$71.3K Buy
+498
New +$71.2K ﹤0.01% 1125

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameritas Advisory Services's DGX Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 90 shares — an estimated $17.2K sold.

Ameritas Advisory Services first reported a position in DGX in Q1 2023 and held it in 3 quarters. The position peaked at $71.3K in Q1 2023. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Ameritas Advisory Services reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 90 Quest Diagnostics shares in Q4 2025, an estimated $17.2K.
  • Ameritas Advisory Services first reported a position in Quest Diagnostics in Q1 2023 and held it in 3 quarters.
  • Ameritas Advisory Services's Quest Diagnostics position peaked at $71.3K in Q1 2023.
  • 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.